Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2000.
Current Awareness.
International Journal of Geriatric Psychiatry,
Vol. 15,
Issue. 11,
p.
1077.
2001.
Other Articles Noted.
Evidence Based Nursing,
Vol. 4,
Issue. 4,
p.
E1.
Neri, M.
Roth, M.
Rubichi, S.
DeVreese, L. P.
Bolzani, R.
and
Cipolli, C.
2001.
The validity of informant report for grading the severity of Alzheimer’s Dementia.
Aging Clinical and Experimental Research,
Vol. 13,
Issue. 1,
p.
22.
Williams, Joanna G.
Huppert, Felicia A.
Matthews, Fiona E.
and
Nickson, Judith
2003.
Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample.
International Journal of Geriatric Psychiatry,
Vol. 18,
Issue. 7,
p.
631.
Amieva, Hélène
Letenneur, Luc
Dartigues, Jean-François
Rouch-Leroyer, Isabelle
Sourgen, Christophe
D’Alchée-Birée, Françoise
Dib, Michel
Barberger-Gateau, Pascale
Orgogozo, Jean-Marc
and
Fabrigoule, Colette
2004.
Annual Rate and Predictors of Conversion to Dementia in Subjects Presenting Mild Cognitive Impairment Criteria Defined according to a Population-Based Study.
Dementia and Geriatric Cognitive Disorders,
Vol. 18,
Issue. 1,
p.
87.
Amieva, Hélène
Phillips, Louise H.
Della Sala, Sergio
and
Henry, Julie D.
2004.
Inhibitory functioning in Alzheimer’s disease.
Brain,
Vol. 127,
Issue. 5,
p.
949.
Amieva, Hélène
Jacqmin-Gadda, Hélène
Orgogozo, Jean-Marc
Le Carret, Nicolas
Helmer, Catherine
Letenneur, Luc
Barberger-Gateau, Pascale
Fabrigoule, Colette
and
Dartigues, Jean-François
2005.
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study.
Brain,
Vol. 128,
Issue. 5,
p.
1093.
Behl, Pearl
Stefurak, Taresa L.
and
Black, Sandra E.
2005.
Progress in Clinical Neurosciences: Cognitive Markers of Progression in Alzheimer's Disease.
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques,
Vol. 32,
Issue. 2,
p.
140.
Martins, C.A.R.
Oulhaj, A.
de Jager, C. A.
and
Williams, J. H.
2005.
APOE
alleles predict the rate of cognitive decline in Alzheimer disease
.
Neurology,
Vol. 65,
Issue. 12,
p.
1888.
Frankfort, S. V.
Appels, B. A.
De Boer, A.
Tulner, L. R.
Van Campen, J. P. C. M.
Koks, C. H. W.
and
Beijnen, J. H.
2006.
Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
International Journal of Clinical Practice,
Vol. 60,
Issue. 6,
p.
646.
Frankfort, S. V.
Appels, B. A.
de Boer, A.
Tulner, L. R.
van Campen, J. P. C. M.
Koks, C. H. W.
Beijnen, J. H.
and
Schmand, B. A.
2007.
Identification of responders and reactive domains to rivastigmine in Alzheimer's disease.
Pharmacoepidemiology and Drug Safety,
Vol. 16,
Issue. 5,
p.
545.
Economou, Alexandra
Papageorgiou, Sokratis G.
Karageorgiou, Clementine
and
Vassilopoulos, Dimitrios
2007.
Nonepisodic Memory Deficits in Amnestic MCI.
Cognitive and Behavioral Neurology,
Vol. 20,
Issue. 2,
p.
99.
Amieva, Hélène
Le Goff, Mélanie
Millet, Xavier
Orgogozo, Jean Marc
Pérès, Karine
Barberger‐Gateau, Pascale
Jacqmin‐Gadda, Hélène
and
Dartigues, Jean François
2008.
Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms.
Annals of Neurology,
Vol. 64,
Issue. 5,
p.
492.
Bermejo, Paloma
Martín-Aragón, Sagrario
Benedí, Juana
Susín, Cristina
Felici, Emanuela
Gil, Pedro
Manuel Ribera, José
and
Villar, Ángel Ma
2008.
Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
Free Radical Research,
Vol. 42,
Issue. 2,
p.
162.
Bermejo, Paloma
Martín-Aragón, Sagrario
Benedí, Juana
Susín, Cristina
Felici, Emanuela
Gil, Pedro
Ribera, José Manuel
and
Villar, Ángel Mª
2008.
Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease.
Immunology Letters,
Vol. 117,
Issue. 2,
p.
198.
Kessels, Roy P.C.
Mimpen, Gerdy
Melis, René
and
Olde Rikkert, Marcel G.M.
2009.
Measuring Impairments in Memory and Executive Function in Older People Using the Revised Cambridge Cognitive Examination.
The American Journal of Geriatric Psychiatry,
Vol. 17,
Issue. 9,
p.
793.
Joshi, Sandhya
Deepa Shenoy, P.
K R, Venugopal
and
Patnaik, L M
2009.
Evaluation of different stages of dementia employing neuropsychological and machine learning techniques.
p.
154.
Wouters, Hans
Zwinderman, Aeilko H.
van Gool, Willem A.
Schmand, Ben
and
Lindeboom, Robert
2009.
Adaptive cognitive testing in dementia.
International Journal of Methods in Psychiatric Research,
Vol. 18,
Issue. 2,
p.
118.
Holland, A.J.
and
Ball, S.L.
2009.
Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities.
p.
107.
Martín-Aragón, Sagrario
Bermejo-Bescós, Paloma
Benedí, Juana
Felici, Emanuela
Gil, Pedro
Ribera, José Manuel
and
Villar, Ángel Ma
2009.
Metalloproteinase’s Activity and Oxidative Stress in Mild Cognitive Impairment and Alzheimer’s Disease.
Neurochemical Research,
Vol. 34,
Issue. 2,
p.
373.